इंग्रजी मध्ये CLOTTING FACTOR म्हणजे काय?
गोठणे
कोयग्युलेशन ही एक प्रक्रिया आहे ज्यामुळे रक्त द्रव पासून एका जेलमध्ये बदलते. हे संभवतः हेमोस्टेसिस मध्ये परिणाम होते, खराब झालेले वायुमधून रक्त कमी होणे, दुरूस्तीनंतर कोयग्युलेशनची कार्यपद्धतीमध्ये प्रथिने, जोडणे आणि प्लेटलेटचे एकत्रीकरण आणि फायब्रिनचे परिपक्वता यांचा समावेश आहे. डेंग्यूलेशनचे विकार रोग स्थिती ज्यामुळे रक्तस्त्राव होऊ शकतो किंवा अडसर अवस्थेत होतात. बुरशीजन्य जीवसृष्टीमध्ये अत्यंत संरक्षित आहे; सर्व सस्तनपामघरात, कोयग्युलेशनमध्ये एक सेल्यूलर आणि प्रोटीन घटक दोन्हीचा समावेश असतो. मानवातील प्रणाली सर्वात जास्त संशोधनात्मक आहे आणि सर्वोत्तम समजली जाते. रक्तवाहिनीला दुखापत झाल्यानंतर कोयप्युलेशन जवळजवळ लगेच सुरु होते ज्यामुळे एन्डोथेमलियम नौकाला अस्तर घातली आहे. एन्डोथेलियमच्या खाली असलेल्या जागेवर रक्ताचा एक्सपोजर दोन प्रक्रियांचा आरंभ करतो: प्लेटलेटमधील बदल आणि सबेडोथिलियल टिशू फॅक्टरचे एक्सपोजर प्लाझ्मा फॅक्टर 7 मध्ये दिले जाते, जे शेवटी फायब्रिन तयार करते. प्लेटलेटला लगेच दुखापतीच्या जागेवर प्लग तयार होतो; याला प्राथमिक हेमोस्टॅसिस असे म्हणतात.
इंग्रजी शब्दकोशातील clotting factor व्याख्या
शब्दकोशातील थडग्यांच्या नलिकेची परिभाषा घटकांचे एक समूह आहे, ज्यामध्ये घटक 8 चे घटक आहेत, रक्त पिठात येणे यासाठी रक्तातील उपस्थिती आवश्यक आहे असे म्हणतात तसेच जसंघ घटक.
«CLOTTING FACTOR» संबंधित इंग्रजी पुस्तके
खालील ग्रंथसूची निवडीमध्ये
clotting factor चा वापर शोधा. इंग्रजी साहित्यामध्ये वापराचा संदर्भ देण्यासाठी
clotting factor शी संबंधित पुस्तके आणि त्याचे थोडक्यात उतारे.
1
Human Physiology: From Cells to Systems
However, chemical linkages rapidly form between adjacent strands to strengthen
and stabilize the clot meshwork. This cross-linkage process is catalyzed by a
clotting factor known as factor XIII (fibrin-stabilizing factor), which normally is ...
Depending on the remaining amount of coagulation factor, mild, moderate and
severe forms of hemophilia are distinguished; two-thirds of cases are severe. In
hemophilia, as a result of the clotting factor deficiency, blood does not coagulate
...
Marshall Cavendish Corporation,
2007
3
Blood: Principles and Practice of Hematology
Patient Plasma 4- aPTT aPTT Result: Correction Interpretation: Clotting Factor
Deficiency EXPLANATION EXPLANATION Free Inhibitor Target • Deficient
Plasma (0% Factor -X') Normal Plasma ( 100% Factor "X") 1:1 Mix (50% Factor "X
") ...
Robert I. Handin, Samuel E. Lux, Thomas P. Stossel,
2003
4
Advanced Nutrition and Human Metabolism
Fibrin Sequence of reactions ➀ Inactive clotting factor X ➁ Vitamin K and Calcium
➃ Fibrinogen Prothrombin (factor II) Factor Xa ➂ Thrombin (factor IIa) Fibrin (
soluble) ➃ Fibrin stabilizing factor (XIIIa) Fibrin (insoluble) A series of reactions ...
Sareen Gropper, Jack Smith,
2008
5
Handbook of Pediatric Transfusion Medicine
Types of Clotting Factor for Treating Hemophilia Clotting factor concentrates
come from two sources, either human plasma donations or production via
recombinant methods from cell cultures. Currently produced human plasma-
derived factor ...
Christopher D. Hillyer, Christopher Hillyer, Ronald Strauss,
2004
6
Biological Monitoring: An Introduction
There is no Factor VI because it has been shown to be activated Clotting Factor V
(Clotting Factor Va: accelerator globulin or proaccelerin). Coagulation involves
interaction of plasma proteins to form a stable fibrin gel. ultimately leading to clot
...
7
Thrombosis and Hemorrhage
The severity of bleeding correlates with the plasma concentration of the clotting
factor (37). Those with a level of factor VIII less than 1% of normal (i.e., severe
hemophilia) have spontaneous hemorrhages and ecchymoses, usually develop
...
Joseph Loscalzo, Andrew I. Schafer,
2003
8
The Absite Question Review Book: Basic Sciences Edition
Exposed collagen, prekallikrein, HMW kininogen, and Clotting Factor 12. What is
the extrinsic pathway activated by? Tissue factor and Clotting Factor 7. Which
clotting factor is the convergence point of both extrinsic and intrinsic pathways?
William M. Greenberg,
2010
9
Medical-surgical Nursing: Patient-centered Collaborative Care
Coagulation or bleeding disorders can result from a clotting factor defect. Defects
include the inability to produce a specific clotting factor, production of low
quantities of a clotting factor, or production Of a less active form of a clotting factor
.
Donna D. Ignatavicius, M. Linda Workman,
2012
10
Consultative Hemostasis and Thrombosis: Expert Consult - ...
Factor VIII dose to be administered = % factor IX dose; 1 U factor VIII concentrate
per kilogram is estimated to raise the clotting factor VIII activity level in plasma by
2%. Consider the use of recombinant factor VIII or IX concentrates in those ...
नवीन गोष्टी ज्यामध्ये «CLOTTING FACTOR» ही संज्ञा समाविष्ट आहे
खालील बातम्यातील आयटमच्या संदर्भात राष्ट्रीय आणि आंतरराष्ट्रीय पत्रकार कशाबद्दल बोलले आहेत आणि
clotting factor ही संज्ञा कशी वापरली आहे ते शोधा.
Omega 3: What is benefits and its source
Omega-3 (EPA) good for the heart: lowers blood pressure, prevents hardening of the arteries and reduces the clotting factor in the blood that ... «Standard Republic, जुलै 15»
Hemophilia Therapeutics Market – Global Industry Analysis and …
Hemophilia is a rare, inherited disorder in which blood doesn't clot normally due to the lack of sufficient blood clotting factor. Clotting factor is a ... «Medgadget.com, जून 15»
Biotech Stocks for you to follow - Biogen Inc (NASDAQ:BIIB …
ALPROLIX is a recombinant, clotting factor IX therapy and is currently approved for the treatment of hemophilia B in the U.S., Canada, Japan ... «Wall Street Observer, जून 15»
EMA accepts marketing authorization application of Alprolix for …
Alprolix is a recombinant, clotting factor IX therapy and is currently approved for the treatment of haemophilia B in the US, Canada, Japan and ... «pharmabiz.com, जून 15»
Sisters tells how their worst fears came true when they passed on …
Both sisters need clotting factor replacement if they have an operation because of their risk of bleeding. They didn't know anything about ... «Scottish Daily Record, जून 15»
Large Cap Stocks Buzz - Baxter (BAX), Kinder Morgan (KMI …
Individuals with hemophilia B lack the ability to produce clotting factor IX and are today treated with infusions of plasma-derived or recombinant ... «Techsonian, जून 15»
Biogen and Sobi Announce European Medicines Agency Validates …
ALPROLIX is a recombinant, clotting factor IX therapy and is currently ... therapy to demonstrate prolonged clotting factor circulation in the body. «MarketWatch, जून 15»
Novo Nordisk reports positive results from phase 3 trial of Novoeight …
... people with hemophilia A must replace the missing factor VIII protein, which is accomplished by intravenous injection of the clotting factor. «pharmabiz.com, जून 15»
Hot Action in 3 Biotech Stocks -Kite Pharma Inc (NASDAQ:KITE …
The company, on June 09, 2015, declared that the company will present new data on its long-acting clotting Factor VIIa-CTP (MOD-5014) at the ... «Wall Street Observer, जून 15»
Novoeight provided long-term efficacy and safety in the treatment of …
... muscles, or organs because they are missing this clotting factor. To manage the disease and stop bleeding, people with haemophilia A must ... «European Pharmaceutical Review, जून 15»